1.Kumar V, Kumar S, Hassan M, Wu H, Thimmulappa RK, Kumar A, Sharma SK, Parmar VS, Biswal S, Malhotra SV.. (2011) Novel chalcone derivatives as potent Nrf2 activators in mice and human lung epithelial cells., 54 (12):[PMID:21539383][10.1021/jm2002348]
2.Kim YS, Kumar V, Lee S, Iwai A, Neckers L, Malhotra SV, Trepel JB.. (2012) Methoxychalcone inhibitors of androgen receptor translocation and function., 22 (5):[PMID:22310230][10.1016/j.bmcl.2011.12.141]
3.Wu J, Wang C, Cai Y, Peng J, Liang D, Zhao Y, Yang S, Li X, Wu X, Liang G. (2012) Synthesis and crystal structure of chalcones as well as on cytotoxicity and antibacterial properties, 21 (4):[10.1007/s00044-011-9549-9]
4.Sharma MC. (2013) Molecular modeling studies of substituted 3,4-dihydroxychalcone derivatives as 5-lipoxygenase and cyclooxygenase inhibitors, [10.1007/s00044-013-0745-7]
5.Bist G, Pun NT, Magar TB, Shrestha A, Oh HJ, Khakurel A, Park PH, Lee ES.. (2017) Inhibition of LPS-stimulated ROS production by fluorinated and hydroxylated chalcones in RAW 264.7 macrophages with structure-activity relationship study., 27 (5):[PMID:28159411][10.1016/j.bmcl.2017.01.061]
6.Iacovino LG, Pinzi L, Facchetti G, Bortolini B, Christodoulou MS, Binda C, Rastelli G, Rimoldi I, Passarella D, Di Paolo ML, Dalla Via L.. (2021) Promising Non-cytotoxic Monosubstituted Chalcones to Target Monoamine Oxidase-B., 12 (7.0):[PMID:34262643][10.1021/acsmedchemlett.1c00238]
